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ABSTRACT 
Objective: The purpose of this study was to develop a green method for assay the tablet consists of a combination of acetaminophen (ACT)-
ibuprofen (IBU). FTIR (Fourier Transform Infrared Spectroscopy), which is commonly used for qualitative analysis, was developed to measure the 
tablet contents, directly and quantitatively.  
Methods: Standard for ACT and IBU was respectively mixed with KBr crystal in varied and measured using FTIR. The transmission spectrum 
yielded later was converted into its absorbance-derivatized forms which then a calibration curve was composed using the data. Once validated, the 
analytical method was conducted on samples of the branded ACT-IBU combination tablet.  
Results: ACT had a specific wavenumber of a group N-H stretch, meanwhile IBU was represented by the C = O spectrum. These peaks then used for 
quantitative calculation basis levels respectively. The limits of detection and quantitation of ACT consecutively were 3.249	 	10
% w/w and 
1.083	 	10
% w/w and IBU were 6.6652	 	10
% w/w and 2.2174 	10
% w/w. Next; the method was carried out successfully to evaluate 
the content of sample tablet from the market.  
Conclusion: The analytical method of ACT-IBU was proven applicable and suitable for the quantitative purpose. The method shows meet with the 
expectation such as simple and easy to perform and reduce the use of solvents.  
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Analgesic, antipyretic and anti-inflammatory are widely used around 
the world because almost of all disease are characterized by pain and 
fever symptoms. The many different types of drugs and forms under 
various trade names and circulated in the free market, pharmacies, 
hospitals, and community health centres. Among the types of pain-
reducing and antipyretic drugs, generally contains a single drug or 
combined drug with an anti-inflammatory. Recently, acetaminophen 
(ACT) has been combined with ibuprofen (IBU) to produce a 
potentiation effect in relieving pain, reducing fever, and inflammation. 
Nonsteroidal anti-inflammatory drugs (NSAID), like IBU, work by 
inhibiting prostaglandin synthesis, suppress inflammation and pain. 
Meanwhile, ACT or commonly known as paracetamol works as a pain 
reducer and temperature control [1-3]. In the market, this 
combination can be found as a tablet dosage form [4]. Therefore, we 
need a suitable method for determining the levels of each active 






Fig. 1: Structure of A. ACT; B. IBU 
 
The structure of ACT and IBU is shown in fig. 1 [5, 6]. The method 
commonly used in compendia to determine the levels of the 
substance in a pharmaceutical preparation is by using high-
performance liquid chromatography instrument. Several researches 
also have reported the development of this compendia's method [7-
12]. However, these methods still required amounts of solvents as 
the mobile phases. Meanwhile, the green pharmacy/green chemistry 
much be recommended for maintain the environment, one of which 
is to reduce the use of organic solvents [13].  
Along the periods, Fourier Transform Infra Red (FTIR) has been 
more widely available due to this important function for 
identification to meet the compendia requirements. Infrared 
spectrum analysis has differences with others in the form division of 
two regions of the spectrum, which are the area of functional groups 
and the fingerprint region. The fingerprint area is a special 
characteristic of each compound. There are some regions of the 
spectrum of infrared but it used the range of the wave number of 
4000-400 cm-1 [12].  
The method used in this research was based on the vibration of 
atoms of a molecule that will generate the spectrum in the form of 
transmission and absorbance. The infrared spectrum was used by 
passing the infrared radiation to a sample, further determines the 
fraction that used the partial absorption of energy. The absorbance 
of infra-red follows Lambert Beer’s Law; as same as the other 
spectroscopy method. Therefore, FTIR also will be tried to be 
conducted as a tool for quantitative analysis [14-17].  
The vibration energy uses the energy which records almost all of the 
interaction in the structures. Hence, infrared is known to have the 
low specificity. In the previous researches, we have tried to develop 
the quantitative method using derivative mathematically. This 
technique has been frequently used to separate the overlaid spectra 
in other spectroscopy methods, such as uv-visible as well as 
spectrofluorometry [18-20]. Using the derivatisation, the lack of 
specificity can overcome successfully. The previous experiments also 
have proven that infrared derivation method is appropriate for 
drugs assay after increasing the sensitivity [21, 22]. The other 
advantages shown by the experiments are: the simpler preparation 
and did not need a solvent. Besides that, compared to the other 
methods which use extraction and dilution, it should be less time 
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consumption, then totally became less costly. Moreover, FTIR 
spectroscopy can be considered as a green analytical method which 
much be recommended nowadays [13, 21, 22].  
So far, derivative spectra FTIR for ACT and IBU determination has 
never been reported. Meanwhile, the measurement of the area 
under the curve (AUC) of derivative of absorbance spectra of some 
drugs has been reported in the previous journal [21, 22]. 
Considering their structure, some infrared spectrums of these 
drugs was predicted can be used for the quantification method. 
Hence, the purpose of this study was to develop and validate FTIR 
method for the assay of ACT and IBU in the tablet directly and 
simultaneously.  
MATERIALS AND METHODS 
Materials  
Reference standards of ACT, IBU, potassium bromide, lactose, 
aerosil, magnesium stearat, and two samples of the brand name of 
ACT-IBU tablets.  
Instrument 
This experiment was using FTIR Jasco-4200 Type A, Japan for the 
record the infrared spectra. 
Methods 
The method arranged to follow the previous research development 
of the direct assay using FTIR using derivated absorbance spectra 
has been reported previously [21, 22]. The derivative spectral has 
been commonly used in other spectrometry, such as uv-visible and 
fluorometry [18-20]. Standards of ACT and IBU are respectively 
mixed with KBr in a varied ratio, beaten into pellets at pressure 10-
20 Mpa, and measured the spectrum. Then the spectrums recorded 
are converted into absorbance. The results next were changed to its 
derivatized form. Derivatization included baseline spectrum 
correction. Wavenumber that showed a clear and distinctive peak of 
each active ingredient is selected and calculated AUC.  
Validation method conducted specificity, linearity, accuracy, 
precision, limit of detection (LOD), limit of quantitation (LOQ), and 
range [23-26]. Once validated, the analytical method is conducted on 
samples of ACT and IBU combination tablet in the market.  
Validation method 
The method was validated for its specificity, linearity, accuracy, 
precision, LOD, LOQ, and range [23-26]. Specificity was evaluated by 
comparing the derivated spectrum of the matrix with simulation tablet. 
The selected range over the spectrum is only found in simulation tablet. 
Linearity was tested for each analyte in concentration range in KBr. 
Linearity was determined by plotting the AUC with concentration (%). 
The acceptance criteria for linearity are as follows (r) ≥ 0.999 and 
variance of regression function (Vxo) ≤ 2% [8].  
Accuracy was evaluated by formulating tablets with the amounts of 
ACT and IBU were 80, 100, and 120%, respectively. Then a number 
of analytes are mixed with KBr into 100 mg. The acceptance 
criterion for accuracy is the recovery value of 98–102% [8]. 
Precision was tested for each number of ACT and IBU with KBr in 
100 mg simulation tablet and was done by repeating measurements 
six times a day. Measurements were also made within three days of 
different analysis times. The precision acceptance criterion is 
relative standard deviation of<2%. Determination of range was 
evaluated by the value of linearity, accuracy, and precision.  
LOD and LOQ were proceeded from the calibration curve [9]. The 
equations are: LOD = 
3 Sy/x
b
; LOQ = 
10 /








Content of tablet combination of ACT and IBU assay was performed 
by sampling 20 tablets from each product. Then tablets were 
weighed, crushed, and mixed homogeneously. Several of them were 
sampled and mixed by means trituration with KBr into 100 mg. 
Measurement by FTIR and determined the AUC over the range of 
corresponding wavenumbers. The concentration of each active 
substance in each sample product can be determined.  
RESULTS AND DISCUSSION 
Content determination ACT and IBU in tablet sample 
The experiment was begun with measured the FTIR spectrum of each 
active substance. Then the spectrum produced each transformed into an 
absorbance. Changing the relationship is because of absorbance values 
proportional to the concentration. Here is a combination of transmission 
spectral of a series concentration of ACT-IBU, which then was converted 
from the transmission into absorbance.  
The ACT’s absorbance-curve is shown in fig. 2. 
  
 
Fig. 2: Absorbance of the ACT 
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Next, the IBU’s spectral is shown in fig. 3.  
 
Fig. 3: Absorbance of IBU 
 
To enhance the specificity, all the absorbance spectrums were derivated [18-22]. The result is shown in fig. 4 for ACT and 5 for IBU.  
 
 
Fig. 4: Derivative absorbance spectra of ACT 
 
Fig. 4 shows the absorbance from six concentrations: 1–6 % 
w/w; which were measured 3 times for each. Moreover, the 
derivative of absorbances based on the data spectra in fig. 4 is 
shown in fig. 5. From the derivative absorbance, the AUC (AUC) 
was measured. Afterwards, resulted from the data of ACT which 
are listed in table 1. 
  
Table 1: ACT’s concentrations versus AUCs of absorbance derivate curve 









1 1.6385 0.8205 1.6528 0.7453 
2 3.0070 1.2398 2.4142 0.9360 
3 4.1971 1.6242 3.1732 1.5481 
4 5.7798 2.0456 3.8596 1.9992 
5 6.9875 2.5350 8.2043 3.0566 
6 8.5576 2.9084 10.1830 3.0566 
r2 0.9986 0.9989 0.8831 0.9551 
Coefficient correlation (r) 0.9992 0.9994 0.9397 0.9772 
*AUC: area under the curve, **Each value is represented as a mean, n=3; SD in this table is not displayed due to the restricted space.  
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Fig. 5: Derivative absorbance spectra of IBU 
 
Based on the selected range of wavenumbers in table 1, the 
highest linearity shown by the spectrum at 3289-3220 cm-1, 
which has r = 0.9994. This is indicated as a group N-H stretch 
[14]. In addition, after the corrections to the matrix, this 
spectrum is specific only for ACT. Thus, the strain of N-H group 
was chosen as the basis for a quantitative calculation. Data from 
these best spectrums was collected and shown in fig. 6. 
Furthermore, the finest IBU spectrum for quantitative measurement 
was investigated. The spectrum which will be selected should meet 
with the validation criterion of linearity and specific. The result 
showed that the spectrum in the area 1847-1758 cm-1, was the most 
linear toward derivate’s absorbance. Moreover, it was also specific, 
due to only held by IBU, which represented C=O stretching [14]. 
Thus, this spectrum was then used for calculate the levels of IBU in 
the sample of combination tablet. For a clear description, the 
derivate spectrums in this area were shown in fig. 7. 
The data of IBU’s AUC measurements are listed in table 2. The table 
shows r value = 0.9992, which proven the good linearity. 
  
 
Fig. 6: Derivative absorbance spectra of ACT at 3289–3220 cm-1 
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Fig. 7: Derivative absorbance spectrum of IBU at 1847-1758 cm-1 
 
Table 2. IBU concentration versus its AUC of derivative-spectra 
Concentration in mixture with KBr (%w/w) AUC of absorbance-derivative  








Correlation coefficient (r) 0.9992 




Specificity test, as the method's ability to analyze accurately, was 
performed to confirm estimated there are as contamination, 
degradation products, and the sample matrix. This method uses the 
specificity test by comparing the absorbance derivative of ACT, IBU, 
matrix, and tablet simulation.  
Derivative absorbance spectrum of the combined ACT, IBU, matrix, 
and tablet simulation yielded shown in fig. 8. Spectrum A belongs to 
ACT but not owned by IBU and the matrix. Meanwhile, B is the 
spectrum which only the spectrum of IBU but not owned by ACT and 
matrix. Thus, these spectrums can be used to measure the levels of 
ACT and IBU in tablet dosage combination of the two substances. 
Linearity 
Linearity is the ability to show the test results directly or through a 
precise mathematical-transformation, that must be shown the 
proportional relation between the concentration with the response. 
Linearity test requires a minimum of five concentrations used, which 
were plotted to AUC of derivative-absorbance. The data from these 
experiments are shown in table 3 and 4 for ACT and IBU 
respectively. Calibration curves yielded from the plotting of 
concentration to AUC were shown in fig. 9 for ACT and fig. 10 for 
IBU. 
ACT’s linearity test 
The data listed in table 3 was plotted into the curve which is shown 
in fig. 9 as follows. 
  
 
Fig. 8: Specific spectrum of ACT (A) and IBU (B), with matrices as background 
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Table 3: ACT concentration versus AUC of the derivative spectra 







*AUC: area under the curve, **Each value is represented as a mean±SD, n=3.  
 
The regression equation of ACT in the range 1.00% to 6.00%: y = 
0.0004 x+0.0004. The coefficient regression was (r) = 0.9994, 
meanwhile Vxo = 0.0309%. Value of r ≥ 0.999 and Vxo ≤ 2.00% stated 
that analytical methods had met the requirements of linearity [23-25]. 
IBU’s linearity test 
Linearity test for IBU yielded data which is listed in table 4. Then, the 
calibration of IBU composed from table 4 data is shown in fig. 10. 
From the curve, the regression equation of IBU was shown linear 
within the range of 1.50% to 4.00%: y = 0.0002 x+0.002. The 
correlation coefficient was (r) = 0.9992, and 0.8063% of Vxo value. 
Value r ≥ 0.999 and Vxo ≤ 2.00% stated that analytical methods had 
met the requirements of linearity [23-25]. 
Accuracy 
Accuracy is the degree of closeness between the test results with a 
validated procedure to correct value. Minimum accuracy 
determination is used nine times, the concentration of 80%, 100% 
and 120% respectively of three measurements, as described in table 
5 and 6 for ACT and IBU. Accuracy is expressed as a percent 
recovery’s analyte is added [23-25]. 
 
Fig. 9: Calibration curve of ACT 
 
 
Fig. 10: Calibration curve of IBU 
 
Table 4: IBU concentration versus AUC of the derivative spectra 







*AUC: area under the curve, **Each value is represented as a mean±SD, n=3 
 
Table 5: Accuration test data of ACT 
Concentration (%) AUC  AUC average  Theoritical AUC Recovery (%) 















*AUC: area under the curve, **Each value is represented as a mean±SD, n=3 
 
Table 6: Accuration test data of IBU 
Concentration (%) AUC AUC average Theoretical AUC Recovery (%) 

















*AUC: area under the curve, **Each value is represented as a mean±SD, n=3 
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Determining the accuracy of ACT tablet simulation performed with 
the active substance content of 280 mg, 350 mg, and 420 mg; with 
the number of excipients were adjusted. Next sampled as much as 
7.5 mg and then each was mixed with KBr so that its mass to 100 mg. 
The same procedure was done to IBU with the doses: 160 mg, 200 
mg, and 240 mg. The results also have met the acceptance recoveries 
requirement: 98.00 to 102.00% w/w [23-25]. 
Precision  
Precision test declared the homogeneous of distribution level 
measurements obtained from multiple samplings under the 
recommended conditions. Its acceptance criteria are expressed 
using relative standard deviation. The kind of tests which were 
performed included:  
Repeatability (precision intra-day)  
Precision intra-day precision expressed under conditions which at 
the same time the interval is narrow [23-25]. In the experiment, 
which yielded data, which is listed in table 7; measurements were 
taken six times the simulation tablet formulations made with levels 
of 350 mg ACT and IBU 200 mg, which is equivalent to 100% in one 
day.
  
Table 7: Intra-day precision data of standard ACT 
Measurement (single) AUC from test on day- 
1 2 3 
1 0.00183 0.00178 0.00178 
2 0.00179 0.00180 0.00177 
3 0.00180 0.00181 0.00183 
4 0.00177 0.00173 0.00182 
5 0.00180 0.00179 0.00179 
6 0.00178 0.00183 0.00181 
Average 0.00179 0.00179 0.00180 
SD 0.00002 0.00002 0.00004 
% RSD 1.15% 0.8 % 1.79% 
% Recovery 99.26% 99.49% 99.81% 
*AUC: area under the curve 
 
Intra-day precision testing of the standard ACT (table 8) yielded the 
relative standard deviation (RSD) of 1.83% on the first day; 1.98% on 
the second day; 1.79% on the third day. The results obtained have met 
the acceptance criteria of precision value RSD of<2% [23-26].  
Intra-day precision testing of raw IBU resulted in RSD of 1.52% on 
the first day; 1.26% on the second day; 1.34% on the third day. The 
results obtained have met the acceptance criteria of precision value 
RSD of<2% [23-26]. 
 
Table 8: Intra-day precision data of standard IBU 
Measurement (single) AUC from test on day- 
1 2 3 
1 0.00248 0.00249 0.00246 
2 0.00242 0.00244 0.00246 
3 0.00246 0.00241 0.00239 
4 0.00239 0.00242 0.00242 
5 0.00246 0.00240 0.00246 
6 0.00248 0.00242 0.00248 
Average 0.00245 0.00243 0.00244 
SD  0.00002  0.00003  0.00004 
% RSD 0.816% 1.12% 1.16% 
% Recovery 101.98% 101.29% 101.86% 
*AUC: area under the curve 
 
Precision intermediates (inter-day precision)  
Precision intermediate shows the variation of testing, for example: 
different days, analysts, equipment, and so forth. At trial, it carried 
out in three days with each measurement performed six times 
respectively, against the tablet simulation. Table 9 shows the result 
of inter-day precision experiment. Meanwhile, the data of IBU’s 
inter-day precision test is expressed in table 10. Based on the results 
of inter-day precision test of ACT and IBU in table 9 and 10, the RSD 
was 0.2767% and 0.3607% respectively. In line with intra-day test 
results, this parameter also has met the acceptance criteria of 
precision stated as<2% [23-25]. 
  






SD  0.00000 
% RSD  0% 
*AUC: area under the curve, **Each value is represented as a mean±SD, n=3 
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SD  0.00001 
% RSD  0.615% 
*AUC: area under the curve, **Each value is represented as a mean±SD, n=3 
 
LOD) and LOQ  
The LOD is the lowest concentration of an analyte, which still can be 
read, represents the sensitivity of the measurement. While the LOQ 
is the smallest concentration of an analyte in a sample which has 
been fulfilled the accuracy and precision requirement. Determining 
LOD and LOQ can be calculated from the linearity data, using b as the 




































 = 1.0830 ×  10

4% w/w 











 = 6.652 ×  10

4 % w/w 
LOQ = 
10 /
 = 2.2174 ×  10

3 % w/w 
Using this method, the LOD of ACT was % w/w or mg per 100 mg 
mixture with KBr. Meanwhile, the LOQ was % w/w or mg ACT per 
100 mg mixture with KBr. Afterwards, the LOD of IBU was % w/w. It 
means that LOD was mg in 100 mg mixture with potassium bromide. 
The smallest amount of sample IBU which can be measured 
quantitatively (LOQ) was % w/w or mg of the substance in 100 mg. 
This LOQ has to appropriate acceptance criteria for accuracy and 
precision.  
Range 
The range is the interval between the highest limit and the lower limit 
of the concentration of an analyte, which can be measured. These 
parameters be determined in line with precision, accuracy and 
linearity of the appropriate procedures specified analysis. Based on 
the linearity test, the concentration range of analysis for ACT was 1.00 
to 6.00% w/w. Meanwhile, for IBU, the range was 1.50 to 4.00% w/w.  
Review and comparison with other methods 
Hence, briefly, the specific spectrums which can be used are the wave 
numbers 3289-3220 for ACT and 1847-1758 cm-1 for IBU, 
simultaneously. This method has been evaluated to meet the 
validation criteria. The parameters checked were: specificity, linearity, 
accuracy, precision intra-day, inter-day precision. The concentration 
range of ACT was 1.00 to 6.00% w/w. For IBU; the range was 1.50 to 
4.00% w/w. The LOD of ACT is % w/w, and LOQ are % w/w. 
Currently; LOD and LOQ of IBU were % w/w and % w/w respectively.  
Furthermore, parameters of validity such as specificity, accuracy, and 
precision are comparable and insignificant different from HPLC 
methods referred [7-12]. The differences are mainly in the range of 
measurement and the LOD/lOQ. In an example, the method which 
newest reported by Jahan et al. (2014) is 25–100 μg/ml for 
paracetamol and 10–40 μg/ml for IBU. Further LOD/lOQ of 
paracetamol is 2.3 μg/ml/0.213 μg/ml and 7.9/0.711 μg/ml 
respectively. These values are about 10-2 smaller than the FTIR 
results, means that the infrared instrument has lower sensitivity. 
However, paracetamol and IBU in the tablet preparation are relatively 
used in big enough dose, so this method is considered still usable and 
appropriate as an alternative. Furthermore, this simultaneous method 
offers some more advantages practically. These are the easy 
preparations, fast to conduct, simple of calculation due to few steps of 
dilution, and free of organic solvent. These advantages will bring to 
totally cost saving and safely for the environment.  
On the other hand, Hoang et al. (2014) also reported derivative 
method of uv spectrophotometry, which showed the calibration 
graphs in the linear concentration ranges of IBU is 12–32 mg/l. 
Meanwhile paracetamol (20–40 mg/l). These values are mostly 
equal to FTIR method recent evaluated. Moreover, this method, as 
same as to HPLC, has validation parameter values such as accuracy 
and precision, statistically interchangeable.  
Finally, in purpose to proof the suitability, this validated FTIR 
quantitative method was tried to determine the weight/content 
uniformity of two branded of ACT-IBU tablets. The results are 
explained in the next part of the discussion (table 12 and 13).  
Determination of levels of ACT and IBU tablet combination  
Assay of a combination of ACT and IBU tablet in samples that found 
from the market was conducted to follow the compendia guidance 
[5,6] using the validated method. The assay was done 
simultaneously on two test product's ACT and IBU combination 
tablet on the market. A total of 20 tablets of each product is weighed 
and crushed. After that, sampled by the number equal to 3.5 mg ACT, 
and IBU was 2.0 mg, then was mixed with KBr and measured using 
FTIR. The experiment yielded data listed in table 12. 
  
Table 12: ACT content in the tablet sample 
Tablet product The average of tablet’s weight (mg) The average of AUC Tablet’s content (mg) Percentage (%w/w) 














* AUC: area under the curve, **Each value is represented as a mean±SD, n=20 
 
From the assay result of ACT, it can be concluded that both products 
from the market have to meet the criteria required by the 
Indonesian Pharmacopoeia [5], levels within the range of 90-110%. 
These results are listed in table 13. 
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Table 13: IBU content in the tablet sample 
Tablet product The weight’s average (mg) The average of AUC Tablet’s content (mg) Percentage (%w/w) 
A 755.175±11.584 0.00242± 
0.00004 
203.836 101.92 





*AUC: area under the curve, **Each value is represented as a mean±SD, n=20 
 
Based on the data, it can be concluded that both products from the 
market have to meet the criteria required by the Indonesian 
Pharmacopoeia: levels IBU should be within the range of 90-110% [5].  
Therefore, all the results have proven that validated FTIR method 
can be used for ACT-IBU quantification in tablet form direct, correct 
and simultaneously. The most advantages of this method is its 
simplicity and less costly than other methods compared.  
CONCLUSION  
FTIR derivative for assay method of ACT and IBU has been validated. 
The method also has been tried to determine the content of ACT-IBU 
tablet combination, and showed the appropriate result, successfully. 
This method is fast, easy, accurate, and free of solvents using. 
Meanwhile, the sensitivity is lower than HPLC. This method shows 
the good accuracy, and precision; besides, is safe and friendlier to 
the environment. In next step, after any comparative test to 
compendia’s, it could be proposed to be the alternative or 
complementary methods.  
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